@entity2622 is the most common @entity5 affecting @entity1 in developing countries like India. This retrospective study was made to analyze our results of radiotherapy alone in the treatment of @entity189 . Between January 1996 and December 2001, 1069 @entity1 of @entity189 were treated at our center with external beam radiotherapy (EBRT) and intracavitary radiotherapy (871) or EBRT alone (198). The median dose to point A was 81 Gy. @entity1349 ( @entity1349 ), disease-free survival (DFS), and pelvic control at 5 years were 51.8%, 49.4%, and 63.9%, respectively. For the @entity1 who could receive intracavitary radiotherapy (871), the @entity1349 , DFS, and pelvic control rates were 60.7%, 58.6%, and 73.5%, respectively. On multivariate analysis, bulk, overall treatment time (OTT) and response to EBRT were found to affect @entity1349 and DFS independently. Similarly, OTT, response to EBRT, stage, and age were the factors that influenced pelvic control. Incidence of severe late @entity137 (grade 3/4) in the rectum, bladder, small intestine, and skin were 1.1%, 1.2%, 0.2%, and 1.2%, respectively. In developing countries like India, where chemoradiation can be afforded by a minority only, judicious use of radiotherapy still produces satisfactory results with acceptable @entity137 . The addition of chemotherapy may be beneficial in @entity1 with adverse prognostic factors.

Results of radiotherapy alone in the treatment of XXXX : a retrospective analysis of 1069 @entity1 .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity137 :: ('MESH:D064420', 'Disease') :: ['toxicity', 'toxicities'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity2622 :: ('MESH:D002583', 'Disease') :: ['Carcinoma of the uterine cervix'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma cervix'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'Overall survival']
@entity2622 :: (MESH:D002583,Disease) :: ['carcinoma of uterine cervix']
